Log in
Enquire now
‌

US Patent 10973807 Pharmaceutical composition comprising pyrrolo-fused six-membered heterocyclic compound

Patent 10973807 was granted and assigned to Jiangsu Hengrui Medicine on April, 2021 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
‌
Jiangsu Hengrui Medicine
Current Assignee
‌
Jiangsu Hengrui Medicine
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10973807
Patent Inventor Names
Yun Lu0
Chenyang Wang0
Tonghui Liu0
Xinhua Zhang0
Date of Patent
April 13, 2021
Patent Application Number
16079589
Date Filed
February 28, 2017
Patent Primary Examiner
‌
Matthew P Coughlin
Patent abstract

The present invention provides a pharmaceutical composition containing a pyrrolo-fused six-membered heterocyclic compound or a pharmaceutically acceptable salt of the compound. Specifically, the invention provides a pharmaceutical composition containing 5-(2-diethylamino-ethyl)-2-(5-fluoro-2-oxo-1,2-dihydro-indol-3-ylidene-methyl)-3-methyl-1,5,6,7-tetrahydro-pyrrolo[3,2-c]pyridin-4-one or a pharmaceutically acceptable salt thereof, and at least one water soluble filler. The pharmaceutical composition of the invention features a rapid dissolution and good stability.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 10973807 Pharmaceutical composition comprising pyrrolo-fused six-membered heterocyclic compound

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us